Nutex Health, Inc. Files 2023 Annual Report on Form 10-K
Ticker: NUTX · Form: 10-K · Filed: Mar 29, 2024 · CIK: 1479681
Sentiment: neutral
Topics: Nutex Health, 10-K, Annual Report, Financials, SEC Filing
TL;DR
<b>Nutex Health, Inc. has filed its 2023 10-K report detailing financial data and corporate history.</b>
AI Summary
Nutex Health, Inc. (NUTX) filed a Annual Report (10-K) with the SEC on March 29, 2024. Nutex Health, Inc. filed its 2023 Form 10-K on March 29, 2024. The company was formerly known as Clinigence Holdings, Inc. and iGambit, Inc. The fiscal year end for Nutex Health, Inc. is December 31. The filing includes data related to common stock, retained earnings, and noncontrolling interest for multiple fiscal years. Key dates and plans mentioned include the September 2023 Private Offering and the Equity Incentive 2022 Plan.
Why It Matters
For investors and stakeholders tracking Nutex Health, Inc., this filing contains several important signals. This filing provides a comprehensive overview of Nutex Health's financial performance and position as of December 31, 2023, crucial for investors assessing the company's stability and growth prospects. The inclusion of historical company names and plan details offers context for understanding the company's evolution and incentive structures.
Risk Assessment
Risk Level: medium — Nutex Health, Inc. shows moderate risk based on this filing. The filing is a 10-K, which is a standard annual report, but the lack of readily available financial summaries like revenue and net income in the provided text suggests a need for deeper analysis of the full document to assess financial health.
Analyst Insight
Investors should review the full 10-K filing to analyze Nutex Health's detailed financial statements, management discussion, and risk factors to make informed investment decisions.
Key Numbers
- 20231231 — Fiscal Year End (The end date of the reporting period.)
- 20240329 — Filing Date (The date the 10-K was filed.)
- 0001479681 — Central Index Key (Unique identifier for Nutex Health, Inc.)
- 7389 — Standard Industrial Classification (Industry code for Nutex Health, Inc.)
- DE — State of Incorporation (The state where Nutex Health, Inc. is incorporated.)
Key Players & Entities
- Nutex Health, Inc. (company) — Filer and subject of the 10-K filing.
- Clinigence Holdings, Inc. (company) — Former name of Nutex Health, Inc.
- iGambit, Inc. (company) — Former name of Nutex Health, Inc.
- EmersonEquityLlcMember (company) — Mentioned in relation to Nutex Health.
- September2023PrivateOfferingMember (company) — Mentioned in relation to Nutex Health.
- AhpHealthManagementServicesInc. (company) — Mentioned in relation to Nutex Health.
- AssociatedHispanicPhysiciansOfSo.CaliforniaMember (company) — Mentioned in relation to Nutex Health.
- Yorkville (company) — Mentioned in relation to Nutex Health.
FAQ
When did Nutex Health, Inc. file this 10-K?
Nutex Health, Inc. filed this Annual Report (10-K) with the SEC on March 29, 2024.
What is a 10-K filing?
A 10-K is a comprehensive annual financial report required by the SEC, covering audited financials, business operations, risk factors, and management discussion. This particular 10-K was filed by Nutex Health, Inc. (NUTX).
Where can I read the original 10-K filing from Nutex Health, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Nutex Health, Inc..
What are the key takeaways from Nutex Health, Inc.'s 10-K?
Nutex Health, Inc. filed this 10-K on March 29, 2024. Key takeaways: Nutex Health, Inc. filed its 2023 Form 10-K on March 29, 2024.. The company was formerly known as Clinigence Holdings, Inc. and iGambit, Inc.. The fiscal year end for Nutex Health, Inc. is December 31..
Is Nutex Health, Inc. a risky investment based on this filing?
Based on this 10-K, Nutex Health, Inc. presents a moderate-risk profile. The filing is a 10-K, which is a standard annual report, but the lack of readily available financial summaries like revenue and net income in the provided text suggests a need for deeper analysis of the full document to assess financial health.
What should investors do after reading Nutex Health, Inc.'s 10-K?
Investors should review the full 10-K filing to analyze Nutex Health's detailed financial statements, management discussion, and risk factors to make informed investment decisions. The overall sentiment from this filing is neutral.
Key Dates
- 2023-12-31: Fiscal Year End — Marks the end of the reporting period for the 10-K.
- 2024-03-29: Filing Date — Date Nutex Health, Inc. submitted its 10-K to the SEC.
Filing Stats: 4,338 words · 17 min read · ~14 pages · Grade level 15.7 · Accepted 2024-03-28 17:33:58
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value NUTX NASDAQ Capital Marke
Filing Documents
- nutx-20231231x10k.htm (10-K) — 3147KB
- nutx-20231231xex4d12.htm (EX-4.12) — 74KB
- nutx-20231231xex4d13.htm (EX-4.13) — 102KB
- nutx-20231231xex10d18.htm (EX-10.18) — 144KB
- nutx-20231231xex10d19.htm (EX-10.19) — 14KB
- nutx-20231231xex10d20.htm (EX-10.20) — 16KB
- nutx-20231231xex10d21.htm (EX-10.21) — 17KB
- nutx-20231231xex10d22.htm (EX-10.22) — 30KB
- nutx-20231231xex10d25.htm (EX-10.25) — 62KB
- nutx-20231231xex10d26.htm (EX-10.26) — 77KB
- nutx-20231231xex10d27.htm (EX-10.27) — 48KB
- nutx-20231231xex10d28.htm (EX-10.28) — 12KB
- nutx-20231231xex10d30.htm (EX-10.30) — 175KB
- nutx-20231231xex10d31.htm (EX-10.31) — 20KB
- nutx-20231231xex21d1.htm (EX-21.1) — 70KB
- nutx-20231231xex23d1.htm (EX-23.1) — 3KB
- nutx-20231231xex31d1.htm (EX-31.1) — 10KB
- nutx-20231231xex31d2.htm (EX-31.2) — 10KB
- nutx-20231231xex32d1.htm (EX-32.1) — 5KB
- nutx-20231231xex32d2.htm (EX-32.2) — 6KB
- nutx-20231231xex97d1.htm (EX-97.1) — 40KB
- nutx-20231231x10k001.jpg (GRAPHIC) — 103KB
- nutx-20231231xex10d18001.jpg (GRAPHIC) — 3KB
- nutx-20231231xex10d18002.jpg (GRAPHIC) — 3KB
- nutx-20231231xex10d18003.jpg (GRAPHIC) — 1KB
- nutx-20231231xex10d19001.jpg (GRAPHIC) — 6KB
- nutx-20231231xex10d19002.jpg (GRAPHIC) — 6KB
- nutx-20231231xex10d28001.jpg (GRAPHIC) — 8KB
- nutx-20231231xex10d28002.jpg (GRAPHIC) — 3KB
- nutx-20231231xex97d1001.jpg (GRAPHIC) — 1KB
- nutx-20231231xex97d1002.jpg (GRAPHIC) — 1KB
- 0001558370-24-004287.txt ( ) — 15716KB
- nutx-20231231.xsd (EX-101.SCH) — 88KB
- nutx-20231231_cal.xml (EX-101.CAL) — 104KB
- nutx-20231231_def.xml (EX-101.DEF) — 354KB
- nutx-20231231_lab.xml (EX-101.LAB) — 772KB
- nutx-20231231_pre.xml (EX-101.PRE) — 615KB
- nutx-20231231x10k_htm.xml (XML) — 2909KB
Risk Factors
Risk Factors 13 Item 1B. Unresolved Staff Comments 36 Item 2.
Properties
Properties 37 Item 3.
Legal Proceedings
Legal Proceedings 37 Item 4. Mine Safety Disclosures 37 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 38 Item 6. Reserved 39 Item 7.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 39 Item 7A.
Quantitative and Qualitative Disclosures about Market Risk
Quantitative and Qualitative Disclosures about Market Risk 53 Item 8.
Financial Statements and Supplementary Data
Financial Statements and Supplementary Data 54 Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure 90 Item 9A.
Controls and Procedures
Controls and Procedures 90 Item 9B. Other Information 91 Item 9C. Disclosures Regarding Foreign Jurisdiction that Prevent Inspections 91 PART III Item 10. Directors, Executive Officers and Corporate Governance 91 Item 11.
Executive Compensation
Executive Compensation 91 Item 12.
Security Ownership of Certain Beneficial Owners and Management And Related Stockholder Matters
Security Ownership of Certain Beneficial Owners and Management And Related Stockholder Matters 91 Item 13. Certain Relationships and Related Transactions and Director Independence 91 Item 14. Principal Accountant Fees and Services 91 Item 15. Exhibits and Financial Statement Schedules 92
Signatures
Signatures 96 Table of Contents PART I
Business
Item 1. Business Overview Nutex Health Inc. ("Nutex Health" or the "Company") is a physician-led, healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. Our hospital division implements and operates innovative health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments ("HOPDs"). The population health management division owns and operates provider networks such as independent physician associations ("IPAs") and offers a cloud-based proprietary technology platform to IPAs which aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers. We employ 800 full-time employees, contract 230 doctors at our facilities and partner with over 1,700 physicians within our networks. Our corporate headquarters is based in Houston, Texas. We were incorporated on April 13, 2000 in the state of Delaware. Operating Segments We report the results of our operations as three segments: (i) the hospital division, (ii) the population health management (PHM) division and (ii) the real estate division. Hospital Division. Our hospital division develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs) providing comprehensive and high-quality 24/7 care. Our full-service care delivery model provides concierge-level care traditionally offered by larger hospitals in a patient-friendly and cost-effective setting. We provide a full spectrum of healthcare services, including emergency room care, inpatient care, and behavioral health, and offer a complementary suite of ancillary services, including onsite imaging (CT scan, X-ray, MRI, ultrasound, etc.), certified and accredited laboratories, and onsite inpatient pharmacies. We own and operate 20 healthcare facilities across eight